2.7.2024
Results on testing MVision AI Contour+ for an ingenious and modern approach in radiation therapy have been recently presented at the 62nd Particle Therapy Co-Operative Group (PTCOG) conference in Singapore. Despite being trained using supine MR data and a different magnetic strength from different scanners, authors reported that MVision AI's…
Articles
28.6.2024
Many regions of the globe face significant disparities between the need of radiation therapy and its availability [1]. Another challenge is providing adequate training for radiation oncology professionals [2]. The cancer burden is expected to rise everywhere, especially the low- and middle-income countries [3]. Artificial intelligence offers a wide range…
14.6.2024
This year, from 10 to 16 June we celebrate the International Men's Health Week. The dates are different each year, so it precedes and includes Father's Day. Multiple activities around the world aim to raise awareness of men’s preventable health problems and early detection (1). The official framework was created…
29.5.2024
Cardiac diseases and cancers are leading causes of death [1]. Many cancer patients have preexistent cardiac impairment or have risk factors of developing it. On the other hand, survival after being diagnosed with cancer is increasing, so relatively more patients may develop long-term side effects. Cardiac diseases and cancers are…
24.5.2024
MVision's configuration solution (ConfigUI) introduces advanced region of interest (ROI) operations and smart post-processing options to support multiple clinical scenarios and complex treatment planning workflows. MVision Contour+ offers an impressive number of structures (more than 270), based on organs or anatomically defined regions, such as lymph node levels. However, we…
21.5.2024
Recently published data give a glimpse on the time spent for treatment preparation in UK radiation oncology centres. As expected,organ-at-risk and target contouring contouring is the most time-consuming step of the process. However, multiple factors influence the amplitude of this interval, and these new findings can be used as further…
14.2.2024
February is the month when Cancer research UK raises awareness about kidney cancer. In 2020 over 400 000 people were diagnosed with this disease, and almost 180 000 died, worldwide. In the UK, there are over 13 000 new cases each year, on average, and almost 5000 lost lives. The…
30.1.2024
Cancer is one of the leading causes of morbidity and death, worldwide. Approximately 18 million people are diagnosed with cancer each year and the number is expected to increase. Pain is experienced by two thirds of patients having advanced, metastatic or terminal disease (1). Other symptoms caused by compression on…
19.1.2024
Results of MVision AI’s solutions scientific evaluation were presented at the previous ASTRO annual meeting. One of the posters included data from paired MRI and synthetic CT scans (MRCAT) of male pelvis and showed the accuracy and consistency of Contour+ models. The abstract was published in Volume 117 Issue 2…
11.1.2024
Dr. Giuseppe Sasso is a Radiation Oncologist with extensive experience in the field, who has been using MVision AI for more than a year already, as an individual customer. He graduated from University of Naples where he also finished residency training 25 years ago. Since then, he has treated patients…
8.1.2024
”Our future is a race between the growing power of technology and the wisdom with which we use it.” This statement of Stephen Hawking, the well known physicist, mathematician and visionary, summarizes very well the present challenges. A new technology, irrespective of its degree of complexity, makes an impact in…
January is Cervical Cancer Awareness Month, and these three core principles are emphasized during the 2024 campaign. Nowadays, cervical cancer is responsible for more than 300,000 deaths each year globally. Fortunately, we have the tools to prevent it, diagnose it early, and treat it efficiently in most cases. This is…
Subscribe to get information, latest news and other interesting offers about MVision AI
